These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30031000)

  • 21. Injectable contraception: emerging evidence on subcutaneous self-administration.
    Lerma K; Goldthwaite LM
    Curr Opin Obstet Gynecol; 2019 Dec; 31(6):464-470. PubMed ID: 31567445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of job aids on knowledge retention among Patent and Proprietary Medicine Vendors trained to administer injectable contraceptives: longitudinal results from implementation science in Nigeria.
    Chace Dwyer S; Jain A; Ishaku SM; Okunade FT; Uzomba C; Adebayo A; Tobey E
    BMC Public Health; 2019 Oct; 19(1):1362. PubMed ID: 31651273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What Distinguishes Women Who Choose to Self-Inject? A Prospective Cohort Study of Subcutaneous Depot Medroxyprogesterone Acetate Users in Ghana.
    Nai D; Tobey E; Fuseini K; Kuma-Aboagye P; Jain A
    Glob Health Sci Pract; 2022 Feb; 10(1):. PubMed ID: 35294390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate.
    Beasley A; White KO; Cremers S; Westhoff C
    Contraception; 2014 May; 89(5):352-6. PubMed ID: 24656555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costs of administering injectable contraceptives through health workers and self-injection: evidence from Burkina Faso, Uganda, and Senegal.
    Di Giorgio L; Mvundura M; Tumusiime J; Namagembe A; Ba A; Belemsaga-Yugbare D; Morozoff C; Brouwer E; Ndour M; Drake JK
    Contraception; 2018 Nov; 98(5):389-395. PubMed ID: 29859148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacist-administered subcutaneous depot medroxyprogesterone acetate: a pilot randomized controlled trial.
    Picardo C; Ferreri S
    Contraception; 2010 Aug; 82(2):160-7. PubMed ID: 20654757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is contraceptive self-injection cost-effective compared to contraceptive injections from facility-based health workers? Evidence from Uganda.
    Di Giorgio L; Mvundura M; Tumusiime J; Morozoff C; Cover J; Drake JK
    Contraception; 2018 Nov; 98(5):396-404. PubMed ID: 30098940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Community-based distribution of injectable contraceptives in an African setting: community trial in Madagascar].
    Brunie A; Hoke TH; Razafindravony B
    Sante; 2011; 21(1):21-6. PubMed ID: 21550921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The scale-up and integration of contraceptive service delivery into nursing school training in the Democratic Republic of the Congo.
    Ntabona A; Binanga A; Bapitani MDJ; Bobo B; Mukengeshayi B; Akilimali P; Kalong G; Mujani Z; Hernandez J; Bertrand JT
    Health Policy Plan; 2021 Jun; 36(6):848-860. PubMed ID: 34009259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility and acceptability of using medical and nursing students to provide Implanon NXT at the community level in Kinshasa, Democratic Republic of Congo.
    Hernandez JH; Akilimali P; Glover A; Bertrand JT
    BMC Womens Health; 2020 Jun; 20(1):133. PubMed ID: 32580766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ugandan providers' views on the acceptability of contraceptive self-injection for adolescents: a qualitative study.
    Cover J; Namagembe A; Tumusiime J; Lim J; Cox CM
    Reprod Health; 2018 Oct; 15(1):165. PubMed ID: 30285779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community Health Workers as Social Marketers of Injectable Contraceptives: A Case Study from Ethiopia.
    Weidert K; Gessessew A; Bell S; Godefay H; Prata N
    Glob Health Sci Pract; 2017 Mar; 5(1):44-56. PubMed ID: 28275087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adolescent and covert family planning users' experiences self-injecting contraception in Uganda and Malawi: implications for waste disposal of subcutaneous depot medroxyprogesterone acetate.
    Burke HM; Packer C; Wando L; Wandiembe SP; Muwereza N; Pradhan S; Zingani A; Ngwira B
    Reprod Health; 2020 Aug; 17(1):117. PubMed ID: 32746860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuation of injectable contraception when self-injected vs. administered by a facility-based health worker: a nonrandomized, prospective cohort study in Uganda.
    Cover J; Namagembe A; Tumusiime J; Nsangi D; Lim J; Nakiganda-Busiku D
    Contraception; 2018 Nov; 98(5):383-388. PubMed ID: 29654751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of training in effective simulated self-injection of subcutaneous depot medroxyprogesterone acetate: observations from a usability study.
    Kaplan I; Ross D; Hilton F; Morgenstern D; Wolter K
    Contraception; 2016 Oct; 94(4):314-20. PubMed ID: 27241898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Acceptability of Community-Based Distribution of Injectable Contraceptives: A Pilot Project in Mozambique.
    Jacinto A; Mobaracaly MR; Ustáb MB; Bique C; Blazer C; Weidert K; Prata N
    Glob Health Sci Pract; 2016 Sep; 4(3):410-21. PubMed ID: 27651076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the feasibility and acceptability of self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA) in Senegal: a prospective cohort study.
    Cover J; Ba M; Lim J; Drake JK; Daff BM
    Contraception; 2017 Sep; 96(3):203-210. PubMed ID: 28673645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and Senegal.
    Burke HM; Mueller MP; Perry B; Packer C; Bufumbo L; Mbengue D; Mall I; Daff BM; Mbonye AK
    Contraception; 2014 May; 89(5):361-7. PubMed ID: 24631328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Society of Family Planning committee consensus on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC).
    Kohn JE; Berlan ED; Tang JH; Beasley A
    Contraception; 2022 Aug; 112():11-13. PubMed ID: 35378085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Provision of DMPA-SC for self-administration in different practice settings during the COVID-19 pandemic: Data from providers across the United States.
    Comfort AB; Alvarez A; Goodman S; Upadhyay U; Mengesha B; Karlin J; Shokat M; Blum M; Harper CC
    Contraception; 2024 Mar; 131():110360. PubMed ID: 38158075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.